MM-111
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MM-111, covering 2014-09-15 to 2017-06-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach [Phase 2]